TRCT
USNA icon

Tower Research Capital (TRC)’s Usana Health Sciences USNA Stock Holding History

Tower Research Capital (TRC)’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.4K Buy
1,170
+363
+45% +$7.2K ﹤0.01% 3467
2025
Q4 		$15.8K Buy
807
+154
+24% +$3.19K ﹤0.01% 3273
2025
Q3 		$18K Sell
653
-1,745
-73% -$53.7K ﹤0.01% 3404
2025
Q2 		$73.2K Buy
2,398
+1,901
+382% +$54K ﹤0.01% 2639
2025
Q1 		$13.4K Sell
497
-1,762
-78% -$55.8K ﹤0.01% 3371
2024
Q4 		$81.1K Sell
2,259
-5,225
-70% -$195K ﹤0.01% 2278
2024
Q3 		$284K Buy
7,484
+5,506
+278% +$226K 0.01% 1303
2024
Q2 		$89.5K Buy
1,978
+1,192
+152% +$54.8K ﹤0.01% 2653
2024
Q1 		$38.1K Sell
786
-3,209
-80% -$157K ﹤0.01% 2461
2023
Q4 		$214K Buy
3,995
+2,414
+153% +$122K ﹤0.01% 2052
2023
Q3 		$92.7K Sell
1,581
-7,386
-82% -$462K ﹤0.01% 2034
2023
Q2 		$565K Buy
8,967
+2,190
+32% +$139K 0.02% 888
2023
Q1 		$426K Buy
6,777
+6,290
+1,292% +$375K 0.01% 930
2022
Q4 		$26K Sell
487
-1,108
-69% -$60K ﹤0.01% 2895
2022
Q3 		$89K Buy
1,595
+1,186
+290% +$78.4K ﹤0.01% 2664
2022
Q2 		$30K Buy
409
+218
+114% +$16.2K ﹤0.01% 3389
2022
Q1 		$15K Buy
191
+54
+39% +$4.87K ﹤0.01% 3842
2021
Q4 		$14K Sell
137
-599
-81% -$59.8K ﹤0.01% 4114
2021
Q3 		$68K Sell
736
-9,028
-92% -$869K ﹤0.01% 2717
2021
Q2 		$1M Buy
9,764
+6,845
+234% +$687K 0.03% 659
2021
Q1 		$285K Sell
2,919
-3,288
-53% -$299K ﹤0.01% 1706
2020
Q4 		$479K Sell
6,207
-5,615
-47% -$434K 0.01% 1020
2020
Q3 		$870K Buy
11,822
+9,942
+529% +$798K 0.01% 1115
2020
Q2 		$138K Buy
1,880
+1,415
+304% +$111K 0.01% 2159
2020
Q1 		$27K Buy
+465
New +$32.3K ﹤0.01% 1580
2019
Q4 		– Sell
-648
Closed -$44K – 4407
2019
Q3 		$44K Buy
648
+310
+92% +$20.8K ﹤0.01% 1896
2019
Q2 		$27K Buy
+338
New +$26.8K ﹤0.01% 1978
2019
Q1 		– Sell
-20
Closed -$2K – 4299
2018
Q4 		$2K Sell
20
-2,306
-99% -$267K ﹤0.01% 3450
2018
Q3 		$280K Sell
2,326
-2,219
-49% -$275K 0.02% 793
2018
Q2 		$524K Sell
4,545
-1,169
-20% -$128K 0.03% 626
2018
Q1 		$491K Buy
5,714
+5,049
+759% +$391K 0.04% 482
2017
Q4 		$49K Sell
665
-835
-56% -$55.9K 0.01% 1352
2017
Q3 		$87K Buy
+1,500
New +$88.6K 0.01% 1496
2017
Q2 		– Sell
-300
Closed -$17K – 3482
2017
Q1 		$17K Sell
300
-580
-66% -$34.6K ﹤0.01% 1405
2016
Q4 		$54K Buy
880
+426
+94% +$27.8K 0.01% 1388
2016
Q3 		$31K Sell
454
-68
-13% -$4.49K ﹤0.01% 1387
2016
Q2 		$29K Buy
522
+322
+161% +$19.4K ﹤0.01% 1957
2016
Q1 		$12K Sell
200
-30
-13% -$1.77K ﹤0.01% 1786
2015
Q4 		$15K Buy
+230
New +$14.9K ﹤0.01% 1630
2015
Q3 		– Sell
-930
Closed -$64K – 4801
2015
Q2 		$64K Sell
930
-1,190
-56% -$75.5K 0.01% 1179
2015
Q1 		$118K Buy
+2,120
New +$109K 0.01% 754
2014
Q3 		– Sell
-1,470
Closed -$57K – 4917
2014
Q2 		$57K Buy
+1,470
New +$54.6K 0.01% 1215
2014
Q1 		– Sell
-1,200
Closed -$45K – 4955
2013
Q4 		$45K Sell
1,200
-710
-37% -$27.2K 0.01% 1486
2013
Q3 		$83K Buy
1,910
+594
+45% +$23.8K 0.01% 1469
2013
Q2 		$48K Buy
+1,316
New +$40K ﹤0.01% 974

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC)'s USNA Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Usana Health Sciences (USNA) stake by 45% in Q1 2026, buying an estimated $7.2K and bringing the position to 1,170 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3467.

Tower Research Capital (TRC) first reported a position in USNA in Q2 2013 and has held it in 45 quarters since. The position peaked at $1M in Q2 2021. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Tower Research Capital (TRC) held 1,170 shares of Usana Health Sciences worth $20.4K as of Q1 2026.
  • Tower Research Capital (TRC) bought 363 Usana Health Sciences shares in Q1 2026, an estimated $7.2K.
  • Usana Health Sciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3467 holding.
  • Tower Research Capital (TRC) first reported a position in Usana Health Sciences in Q2 2013 and has held it in 45 quarters since.
  • Tower Research Capital (TRC)'s Usana Health Sciences position peaked at $1M in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.